Comparison of effectiveness and safety between ticagrelor and clopidogrel in patients with acute coronary syndrome and on dialysis in Taiwan
- 3 June 2021
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 88 (1) , 145-154
Abstract
Aims: This study aimed to evaluate and compare the effectiveness and safety between clopidogrel and ticagrelor in acute coronary syndrome (ACS) with renal dysfunction.Methods: We conducted a retrospective cohort study on patients on chronic dialysis and whose admission diagnosis between 1 July 2013 and 31 December 2016 included ACS. The primary effectiveness endpoint was a major adverse cardiovascular event (MACE), and the primary safety endpoint was a major bleeding event. The application of propensity scores through the inverse probability of treatment weighting (IPTW) was applied to the study groups. Cox regression was used to estimate hazard ratios (aHRs) of study endpoints. In addition, the competing risk was adjusted using the Fine and Gray competing risk model.Results: There were 1915 patients in the clopidogrel group and 270 patients in the ticagrelor group. At 12 months, the ticagrelor group had higher risks for MACE (aHR with IPTW: 1.29; 95% CI 1.16–1.44); death (aHR with IPTW: 1.65; 95% CI 1.47–1.86) and cardiac death (subdistribution HR [SHR] with IPTW: 1.64; 95% CI 1.41–1.91), compared with those in the clopidogrel group. For major bleeding event, the risk was significantly higher with ticagrelor than with clopidogrel (SHR with IPTW: 1.49; 95% CI 1.34–1.65). In terms of the risk for any bleeding event, there was no significant difference between the two groups (SHR with IPTW: 1.05; 95% CI 0.95–1.17).Conclusions: Compared with clopidogrel, ticagrelor was associated with higher MACE, death, cardiac death and major bleeding risk within 12 months in patients with ACS and on dialysis.Keywords
Funding Information
- Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH107‐M715)
This publication has 32 references indexed in Scilit:
- Gastrointestinal bleeding in patients on long-term dialysisJournal Of Nephrology, 2014
- Propensity Score Methods for Confounding Control in Nonexperimental ResearchCirculation: Cardiovascular Quality and Outcomes, 2013
- Survie et mortalité des patients en IRCTNephrologie & Therapeutique, 2013
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and preventionThe Lancet, 2013
- China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysisBMC Nephrology, 2012
- Enhanced Clopidogrel Responsiveness in SmokersArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal FunctionCirculation, 2010
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2009
- Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: A potential contributor to cardiovascular riskAmerican Journal of Kidney Diseases, 2002
- Antihypertensive drugs and the risk of gastrointestinal bleedingThe American Journal of Medicine, 1998